Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sublingual immunotherapy: an update.

Giovanni Passalacqua1, Carlo Lombardi, Giorgio Walter Canonica

  • 1Allergy & Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy. passalacqua@unige.it

Current Opinion in Allergy and Clinical Immunology
|April 20, 2004
PubMed
Summary

Sublingual immunotherapy (SLIT) offers a long-lasting effect for allergies, preventing new sensitizations and showing satisfactory adherence. Recent studies confirm its clinical value, comparable to subcutaneous immunotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small airway dysfunction: a key predictor of exacerbation risk in adolescents with mild, well-controlled asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

The journal of allergy and clinical immunology. In practice·2026
Same author

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Expert opinion on biological therapy·2026
Same author

Renal-diabetic overlap in pulmonary arterial hypertension.

Heart (British Cardiac Society)·2026
Same author

Small Airway Dysfunction May Mediate the Association Between Body Mass Index and Severe Asthma Exacerbations.

The European respiratory journal·2026
Same author

Allergen-specific immunotherapy at earlier stages of allergic respiratory diseases: a change is in the air!

Current opinion in allergy and clinical immunology·2026

Area of Science:

  • Allergy and Immunology
  • Immunotherapy Research

Background:

  • Sublingual immunotherapy (SLIT) is an accepted alternative to subcutaneous immunotherapy, widely adopted in Europe.
  • Despite established efficacy, questions regarding SLIT's long-term benefits, adherence, and preventive potential persist.

Purpose of the Study:

  • To review recent evidence addressing concerns about sublingual immunotherapy's efficacy, adherence, and long-lasting effects.
  • To evaluate the clinical value and comparative effectiveness of SLIT against traditional methods.

Main Methods:

  • Systematic review of recently published studies on sublingual immunotherapy.
  • Meta-analysis to confirm efficacy in specific allergic conditions like rhinitis and conjunctivitis.
  • Assessment of adherence data and long-term follow-up studies.

Related Experiment Videos

Main Results:

  • SLIT demonstrates a durable effect lasting up to 5 years post-treatment and prevents new allergic sensitizations.
  • Patient adherence to self-administered SLIT is generally satisfactory.
  • Evidence supports SLIT's efficacy in allergic conjunctivitis and rhinitis, with potential for simplified administration schedules.

Conclusions:

  • Emerging data consistently affirm the clinical significance of sublingual immunotherapy.
  • SLIT is clinically comparable to subcutaneous immunotherapy across multiple parameters.
  • Ongoing research continues to validate and refine SLIT as a valuable therapeutic option for allergic diseases.